6al5

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (14:19, 4 October 2023) (edit) (undo)
 
Line 1: Line 1:
==COMPLEX BETWEEN CD19 (N138Q MUTANT) AND B43 FAB==
==COMPLEX BETWEEN CD19 (N138Q MUTANT) AND B43 FAB==
-
<StructureSection load='6al5' size='340' side='right' caption='[[6al5]], [[Resolution|resolution]] 3.00&Aring;' scene=''>
+
<StructureSection load='6al5' size='340' side='right'caption='[[6al5]], [[Resolution|resolution]] 3.00&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
-
<table><tr><td colspan='2'>[[6al5]] is a 3 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6AL5 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6AL5 FirstGlance]. <br>
+
<table><tr><td colspan='2'>[[6al5]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6AL5 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6AL5 FirstGlance]. <br>
-
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
+
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3&#8491;</td></tr>
-
<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=PCA:PYROGLUTAMIC+ACID'>PCA</scene></td></tr>
+
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=PCA:PYROGLUTAMIC+ACID'>PCA</scene></td></tr>
-
<tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">CD19 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN]), IGK@ ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
+
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6al5 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6al5 OCA], [https://pdbe.org/6al5 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6al5 RCSB], [https://www.ebi.ac.uk/pdbsum/6al5 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6al5 ProSAT]</span></td></tr>
-
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6al5 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6al5 OCA], [http://pdbe.org/6al5 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6al5 RCSB], [http://www.ebi.ac.uk/pdbsum/6al5 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6al5 ProSAT]</span></td></tr>
+
</table>
</table>
== Disease ==
== Disease ==
-
[[http://www.uniprot.org/uniprot/CD19_HUMAN CD19_HUMAN]] Common variable immunodeficiency. The disease is caused by mutations affecting the gene represented in this entry.
+
[https://www.uniprot.org/uniprot/CD19_HUMAN CD19_HUMAN] Common variable immunodeficiency. The disease is caused by mutations affecting the gene represented in this entry.
== Function ==
== Function ==
-
[[http://www.uniprot.org/uniprot/CD19_HUMAN CD19_HUMAN]] Assembles with the antigen receptor of B-lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation.
+
[https://www.uniprot.org/uniprot/CD19_HUMAN CD19_HUMAN] Assembles with the antigen receptor of B-lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation.
<div style="background-color:#fffaf0;">
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
== Publication Abstract from PubMed ==
Line 22: Line 21:
</div>
</div>
<div class="pdbe-citations 6al5" style="background-color:#fffaf0;"></div>
<div class="pdbe-citations 6al5" style="background-color:#fffaf0;"></div>
 +
 +
==See Also==
 +
*[[Antibody 3D structures|Antibody 3D structures]]
 +
*[[Monoclonal Antibodies 3D structures|Monoclonal Antibodies 3D structures]]
== References ==
== References ==
<references/>
<references/>
__TOC__
__TOC__
</StructureSection>
</StructureSection>
-
[[Category: Human]]
+
[[Category: Homo sapiens]]
-
[[Category: Gilliland, G L]]
+
[[Category: Large Structures]]
-
[[Category: Obmolova, G]]
+
[[Category: Gilliland GL]]
-
[[Category: Teplyakov, A]]
+
[[Category: Obmolova G]]
-
[[Category: Immune system]]
+
[[Category: Teplyakov A]]

Current revision

COMPLEX BETWEEN CD19 (N138Q MUTANT) AND B43 FAB

PDB ID 6al5

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/6al5"
Personal tools